Appendix 10Incremental cost-effectiveness scatterplots and cost-effectiveness acceptability figures
Incremental cost-effectiveness scatterplot of UDS vs. clinical history for women successfully treated.
Cost-effectiveness acceptability frontier for the comparison between UDS and clinical history for the case of women successfully treated.
Incremental cost-effectiveness scatterplot of UDS vs. clinical history for QALYs.
Cost-effectiveness acceptability frontier for the comparison between UDS and clinical history for the case of QALYs.
Incremental cost-effectiveness scatterplot of UDS vs. clinical history for DO cases detected.
Cost-effectiveness acceptability frontier for the comparison between UDS and clinical history for the case of DO cases detected.
Cost-effectiveness plane showing the mean cost and clinical effectiveness (women successfully treated) for all strategies.
Scatterplot showing the uncertainty in costs and effectiveness (women successfully treated) for all strategies.
Cost-effectiveness acceptability frontier for the comparison between UDS, clinical history and bladder ultrasonography in MUI and clinical history and UDS in MUI for the case of women successfully treated.
Cost-effectiveness plane showing the mean cost and clinical effectiveness (QALYs) for all strategies.
Scatterplot showing the uncertainty in costs and effectiveness (QALYs) for all strategies.
Cost-effectiveness acceptability frontier for the comparison between UDS, clinical history and bladder ultrasonography in MUI and clinical history and UDS in MUI for the case of QALYs.
Cost-effectiveness plane showing the mean cost and clinical effectiveness (DO cases detected) for all strategies.
Cost-effectiveness acceptability frontier for the comparison between UDS, clinical history and bladder ultrasonography in MUI and clinical history and UDS in MUI for the case of DO cases detected.
Population EVPI for the main outcome measure (primary analysis).
Population EVPI for the main outcome measure (secondary analysis).